Cargando…

Cisplatin as neoadjuvant chemotherapy in triple negative breast cancer: Exciting early results

Detalles Bibliográficos
Autores principales: Goel, Arun Kumar, Nandy, Malay, Sharma, Gopal
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3009437/
https://www.ncbi.nlm.nih.gov/pubmed/21206711
http://dx.doi.org/10.4103/0971-5851.73588
_version_ 1782194680638734336
author Goel, Arun Kumar
Nandy, Malay
Sharma, Gopal
author_facet Goel, Arun Kumar
Nandy, Malay
Sharma, Gopal
author_sort Goel, Arun Kumar
collection PubMed
description
format Text
id pubmed-3009437
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-30094372011-01-04 Cisplatin as neoadjuvant chemotherapy in triple negative breast cancer: Exciting early results Goel, Arun Kumar Nandy, Malay Sharma, Gopal Indian J Med Paediatr Oncol Commentary Medknow Publications 2010 /pmc/articles/PMC3009437/ /pubmed/21206711 http://dx.doi.org/10.4103/0971-5851.73588 Text en © Indian Journal of Medical and Paediatric Oncology http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Commentary
Goel, Arun Kumar
Nandy, Malay
Sharma, Gopal
Cisplatin as neoadjuvant chemotherapy in triple negative breast cancer: Exciting early results
title Cisplatin as neoadjuvant chemotherapy in triple negative breast cancer: Exciting early results
title_full Cisplatin as neoadjuvant chemotherapy in triple negative breast cancer: Exciting early results
title_fullStr Cisplatin as neoadjuvant chemotherapy in triple negative breast cancer: Exciting early results
title_full_unstemmed Cisplatin as neoadjuvant chemotherapy in triple negative breast cancer: Exciting early results
title_short Cisplatin as neoadjuvant chemotherapy in triple negative breast cancer: Exciting early results
title_sort cisplatin as neoadjuvant chemotherapy in triple negative breast cancer: exciting early results
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3009437/
https://www.ncbi.nlm.nih.gov/pubmed/21206711
http://dx.doi.org/10.4103/0971-5851.73588
work_keys_str_mv AT goelarunkumar cisplatinasneoadjuvantchemotherapyintriplenegativebreastcancerexcitingearlyresults
AT nandymalay cisplatinasneoadjuvantchemotherapyintriplenegativebreastcancerexcitingearlyresults
AT sharmagopal cisplatinasneoadjuvantchemotherapyintriplenegativebreastcancerexcitingearlyresults